Eximius Pharmaceuticals Private Limited
About Eximius Pharmaceuticals Private Limited
Data last updated:
Eximius Pharmaceuticals Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 24 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74120TG2015PTC101908.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Purna Chandra Padhi (Managing Director) and Pratima Padhi.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at F – 306 Santoshima Apartment Santoshima Nagar Naredment, Secunderabad, Telangana, India – 500056.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.99 Lakh, a growth of 30% compared to the previous year. For the same year it recorded a net loss of ₹6,673 (net margin -1.3%) and EBITDA of ₹3,075 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Eximius Pharmaceuticals Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF – 306 Santoshima Apartment Santoshima Nagar Naredment, Secunderabad, Telangana, India – 500056
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Eximius Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Eximius Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eximius Pharmaceuticals Private Limited, buy the company report.
Financials of Eximius Pharmaceuticals Private Limited
FY 2024 filings availableEximius Pharmaceuticals Private Limited reported revenue of ₹4.99 Lakh (up 30% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 30% growth in the latest year. EBITDA fell 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,075 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6,673 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | -1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eximius Pharmaceuticals Private Limited, buy the company report.
Board of directors of Eximius Pharmaceuticals Private Limited
Eximius Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pratima Padhi | Director | 24 Nov 2015 | 10 Years 10 Months | Current |
| Purna Chandra Padhi | Managing Director | 24 Nov 2015 | 10 Years 10 Months | Current |
Peer comparison
Eximius Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eximius Pharmaceuticals Private Limitedthis company | ₹4.99 Lakh (FY 2024) | -₹6,673 | -1.3% | 30.0% | Secunderabad, Telangana, India | |
| Admak Pharmaceuticals Private Limited | ₹4.98 Lakh (FY 2025) | 35.0% | Mumbai, Maharashtra, India | |||
| Arsinoe Pharmaceuticals Private Limited | ₹4.97 Lakh (FY 2025) | Bhopal, Madhya Pradesh, India | ||||
| Evans Pharmaceuticals Private Limited | ₹4.94 Lakh (FY 2025) | 16.0% | Kozhikode, Kerala, India |
To see the full peer comparison of Eximius Pharmaceuticals Private Limited, buy the company report.
Auditor
Eximius Pharmaceuticals Private Limited is audited by JAJATI AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAJATI AND ASSOCIATES | FY 2017 | 322920E |
Shareholding
The shareholding of Eximius Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Eximius Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Eximius Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eximius Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Eximius Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Eximius Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Pratima Padhi was appointed as Director on 24 Nov 2015.
Frequently asked questions
Eximius Pharmaceuticals is an active private limited company based in Secunderabad, Telangana, India. The company works in other wholesale, within the trading industry. It was incorporated on 24 November 2015 (11+ years old) and is registered under CIN U74120TG2015PTC101908.
Eximius Pharmaceuticals has 2 current directors:
- Purna Chandra Padhi - Managing Director
- Pratima Padhi - Director
The latest financial statements of Eximius Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Eximius Pharmaceuticals is U74120TG2015PTC101908. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eximius Pharmaceuticals was incorporated on 24 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Eximius Pharmaceuticals by revenue are Admak Pharmaceuticals Private Limited, Arsinoe Pharmaceuticals Private Limited, Evans Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Pratima Padhi was appointed as Director on 24 Nov 2015. Purna Chandra Padhi was appointed as Managing Director on 24 Nov 2015.
The registered office of Eximius Pharmaceuticals is at F – 306 Santoshima Apartment Santoshima Nagar Naredment, Secunderabad, Telangana, India – 500056.
Eximius Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Eximius Pharmaceuticals is compliant as of 23 September 2026. The company is actively filing with the Registrar of Companies.
Eximius Pharmaceuticals can be reached at its registered office: F – 306 Santoshima Apartment Santoshima Nagar Naredment, Secunderabad, Telangana, India – 500056.